Management of Frailty in Older Adults With Turmeric and Tulsi Supplements

NCT ID: NCT03365310

Last Updated: 2018-04-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-07-01

Study Completion Date

2018-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to determine the efficacy of turmeric and tulsi polyherbal formulation in the management of frailty in the elderly population.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Frailty is a wasting syndrome of old age that leaves a person vulnerable to falls, functional decline, morbidity and mortality. Reducing the severity of frailty will provide large benefits for individuals, their families and for the society. It is assumed that early intervention with frail people will improve quality of life and reduce the costs of care. This trial is testing the frailty intervention with herbal medicine. If this frailty intervention is shown to be effective, there are major potential benefits to the frail older population generally in terms of decreased disability. The interventions being examined are readily transferable to routine clinical practice and can potentially be applied routinely in aged care services.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Frail Elderly Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Parallel follow up of two treatment groups randomly allocated through a central randomization process
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

open label study

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention Group

Participants will receive turmeric and tulsi capsule with milk(100 ml) along with standard of care treatment as determined by research physician...Each participants has to take two capsules of turmeric formula and tulsi twice daily for the study period of 3 months

Group Type EXPERIMENTAL

C. longa, curcuminoids , Z. officianale, O. sanctum along with 200 ml of Milk

Intervention Type DRUG

Polyherbal formulation along with standard of care

Standard of Care

Intervention Type OTHER

Usual standard of care for consist of exercise, caloric and protein support, vitamin D, reduction of polypharmacy along with medical management of health condition, assessment of care needs and provision of care. These will be determined on case by case basis by research clinician.

Standard Care Group

Participants will only receive the standard of care treatment as determined by research physician

Group Type ACTIVE_COMPARATOR

Standard of Care

Intervention Type OTHER

Usual standard of care for consist of exercise, caloric and protein support, vitamin D, reduction of polypharmacy along with medical management of health condition, assessment of care needs and provision of care. These will be determined on case by case basis by research clinician.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

C. longa, curcuminoids , Z. officianale, O. sanctum along with 200 ml of Milk

Polyherbal formulation along with standard of care

Intervention Type DRUG

Standard of Care

Usual standard of care for consist of exercise, caloric and protein support, vitamin D, reduction of polypharmacy along with medical management of health condition, assessment of care needs and provision of care. These will be determined on case by case basis by research clinician.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Turmeric formula and Tulsi capsule and Milk

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects above the age of 65 years, providing written informed consent.
* Meeting three or more Cardiovascular health study frailty criteria
* Mild or no cognitive impairment (defined as a Mini-Mental State Examination score \>23),
* Able to walk without personal assistance and no other physical limitations that can limit participation and adherence, particularly to exercise intervention program

Exclusion Criteria

People will be ineligible to participate in the trial if they:

* Live in a residential aged care facility
* Severe audio-visual impairment
* Progressive, degenerative neurologic disease like Parkinsonism, fits/ epilepsy, etc.
* Rapidly progressive or terminal illness under palliative care with life expectancy less than 12 months
* History of alcohol abuse or any other substance abuse
* Severely affect muscle/joint dysfunction resulting in disability
* Hospital admission in the past 3 months
* Regular physical training or physiotherapy or current participation in a vigorous exercise or weight-training program more than once per week
* Undergoing therapeutic diet incompatible with nutritional supplementation
* In the opinion of research clinician, the intervention is deemed to be potentially hazardous for the subject, such as serious cardiac and pulmonary disease.
Minimum Eligible Age

65 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Composite Interceptive Med Science

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dr. Sanjaya Chauhan

Role: PRINCIPAL_INVESTIGATOR

Composite Interceptive Med Science

Dr. Alben Sigamani

Role: PRINCIPAL_INVESTIGATOR

Narayana Hrudayalaya Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mazumdar Shaw Medical Centre

Bangalore, Karnataka, India

Site Status

Countries

Review the countries where the study has at least one active or historical site.

India

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Alben Sigamani

Role: CONTACT

8884431444

Sanjaya Chauhan

Role: CONTACT

9611252350

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Alben Sigamani, MD

Role: primary

8884431444

Sanjaya Chauhan, Pharm.D

Role: backup

9611252350

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OI-007-2017

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Oral Curcumin for Radiation Dermatitis
NCT01246973 COMPLETED PHASE2/PHASE3